Stock Price Quote

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE281.15-2.55 (-0.9 %)
PREV CLOSE ( ) 283.70
OPEN PRICE ( ) 283.10
BID PRICE (QTY) 281.15 (16)
OFFER PRICE (QTY) 281.40 (373)
VOLUME 1297458
TODAY'S LOW / HIGH ( )281.00 284.90
52 WK LOW / HIGH ( )258.3 410.5
NSE281.45-2.1 (-0.74 %)
PREV CLOSE( ) 283.55
OPEN PRICE ( ) 284.20
BID PRICE (QTY) 281.25 (138)
OFFER PRICE (QTY) 281.40 (101)
VOLUME 765327
TODAY'S LOW / HIGH( ) 281.00 285.30
52 WK LOW / HIGH ( )258.25 410.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-11 1978
Management Info
Kiran Mazumdar-Shaw - Chairman Siddharth Mittal - Managing Director
Registered Office

Address 20th Km,Hosur Road,Electronic City,
Bengaluru,
Karnataka-560100

Phone 080 2808 2808

Email corporate.communications@biocon.com

Website www.biocon.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

01Dec Biocon informs about analyst meet
Pursuant to Regulation 30(6) of the SEBI LODR Regulations, 2015, Biocon..
01Dec Biocon informs about analyst meet
Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, Biocon..
30Nov Biocon’s arm completes acquisition of
Biocon’s subsidiary -- Biocon Biologics has successfully completed its m..
24Nov Biocon signs semi-exclusive partnershi
Biocon has signed semi-exclusive partnership agreement with Zentiva, a l..
24Nov Biocon inches up on signing semi-exclu
Biocon is currently trading at Rs. 280.75, up by 0.65 points or 0.23% fr..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit9875861
Gross Profit 11061 1397
Operating Profit 12672483
Net Sales 489517382

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Fredun Pharma (BSE)
peergroup  1368.00 (4.00%)
M.Cap ( in Cr)598.66
Medplus Health Servi (BSE)
peergroup  714.40 (5.86%)
M.Cap ( in Cr)8510.67
TTK Healthcare (BSE)
peergroup  940.00 (3.23%)
M.Cap ( in Cr)1317.94
Piramal Enterprises (BSE)
peergroup  888.85 (3.42%)
M.Cap ( in Cr)21194.53
Astrazeneca Pharma I (BSE)
peergroup  3304.70 (0.89%)
M.Cap ( in Cr)8261.25

Shareholding Pattern

PROMOTERS 60.64%
FI/BANKS/INSURANCE 4.55%
MUTUAL FUNDS/UTI 3.21%
NON-INSTITUTION 15.81%
GOVERNMENT 0%
FII 0%

About Biocon Ltd.

Biocon Ltd. was incorporated in the year 1978. Its today's share price is 281.15. Its current market capitalisation stands at Rs 33832.91 Cr. In the latest quarter, company has reported Gross Sales of Rs. 17382 Cr and Total Income of Rs.19254 Cr. The company's management includes Peter Bains, Mayank Verma, Naina Lal Kidwai, Vijay Kumar Kuchroo, Bobby Kanubhai Parikh, Meleveetil Damodaran, Eric Vivek Mazumdar, Ravi Rasendra Mazumdar, Siddharth Mittal, Kiran Mazumdar-Shaw.

It is listed on the BSE with a BSE Code of 532523 , NSE with an NSE Symbol of BIOCON and ISIN of INE376G01013. It's Registered office is at 20th Km,Hosur Road,Electronic CityBengaluru-560100, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)